KeyBank National Association’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Sell
6,731
-681
-9% -$46.4K ﹤0.01% 900
2026
Q1
$479K Buy
7,412
+34
+0.5% +$2.4K ﹤0.01% 852
2025
Q4
$497K Sell
7,378
-93
-1% -$6.26K ﹤0.01% 815
2025
Q3
$548K Sell
7,471
-3,369
-31% -$224K ﹤0.01% 751
2025
Q2
$564K Sell
10,840
-1,102
-9% -$62.7K ﹤0.01% 727
2025
Q1
$762K Sell
11,942
-157
-1% -$9.12K ﹤0.01% 614
2024
Q4
$578K Sell
12,099
-48
-0.4% -$2.46K ﹤0.01% 733
2024
Q3
$695K Buy
+12,147
New +$696K ﹤0.01% 660
2022
Q3
– Sell
-5,333
Closed -$235K – 1061
2022
Q2
$235K Sell
5,333
-1,584
-23% -$68.5K ﹤0.01% 960
2022
Q1
$276K Buy
6,917
+3
+0% +$107 ﹤0.01% 938
2021
Q4
$278K Sell
6,914
-697
-9% -$26K ﹤0.01% 967
2021
Q3
$310K Sell
7,611
-21
-0.3% -$878 ﹤0.01% 933
2021
Q2
$347K Sell
7,632
-494
-6% -$21.9K ﹤0.01% 895
2021
Q1
$339K Sell
8,126
-275
-3% -$12.6K ﹤0.01% 894
2020
Q4
$359K Buy
+8,401
New +$302K ﹤0.01% 856

Other funds holding HALO

KeyBank National Association's HALO Position: Q2 2026 in Review

KeyBank National Association reduced its Halozyme (HALO) stake by 9.2% in Q2 2026, selling an estimated $46.4K and leaving 6,731 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

KeyBank National Association first reported a position in HALO in Q4 2020 and has held it in 15 quarters since. The position peaked at $762K in Q1 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • KeyBank National Association held 6,731 shares of Halozyme worth $527K as of Q2 2026.
  • KeyBank National Association sold 681 Halozyme shares in Q2 2026, an estimated $46.4K.
  • Halozyme made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #900 holding.
  • KeyBank National Association first reported a position in Halozyme in Q4 2020 and has held it in 15 quarters since.
  • KeyBank National Association's Halozyme position peaked at $762K in Q1 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.